Endo International | ENDP - Umsatzerlöse



Der Umsatz Veränderung Datum
AbbVie USD 15B 1.62B 2026-03
Amarin USD 49.22M 451K 2025-12
ANI Pharmaceuticals USD 247.06M 19.25M 2025-12
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Coherus Biosciences USD 12.75M 1.18M 2025-12
Eli Lilly USD 19.8B 500M 2026-03
Heron Therapeutics USD 40.59M 2.38M 2025-12
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Ligand Pharmaceuticals USD 59.66M 55.8M 2025-12
Merck USD 16.29B 110M 2026-03
Novartis USD 13.11B 226M 2026-03
Pacira USD 196.87M 17.35M 2025-12
Perrigo USD 1.11B 70M 2025-12
Pfizer USD 17.58B 880M 2025-12
Phibro Animal Health USD 373.91M 10.02M 2025-12
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
Takeda JPY 1.19T 80B 2025-12
Teva Pharmaceutical Industries USD 11.77B 2.86B 2026-03
Xeris Pharmaceuticals USD 85.81M 11.43M 2025-12
Zoetis USD 2.4B 0 2025-12